PTHS · Healthcare · $73M
$20.92-1.55%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
“매출이 1분기 1,070만 달러에서 2분기 1,540만 달러로 45% 늘어났고, 최근 흐름도 700만 달러→900만 달러→1,100만 달러→1,”
In the company's words · 2026 2분기 earnings call